产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
猜你想搜
首页 制药产品大全 药品制剂 Bivalirudin Inj...

Bivalirudin Injection 0.25g

2026-10-31
苏州市
是

产品详情

Bivalirudin Injection 0.25g
酶类及其他生化类制剂
Bivalirudin Injection 0.25g/=acts as a potent and reversible "blood thinner"
否
Vial: 0.25g
Vial
1000个
capacity >1,000,000 pcs
2weeks-4weeks
中国,北美洲,东欧,亚洲,中东
是
收费
无
Vial: 0.25g

产品描述

Bivalirudin Injection 0.25g (250 mg) is an intravenous, direct thrombin inhibitor anticoagulant. On platforms like Wikipedia or Wikidoc, it is classified as a synthetic 20-amino acid peptide that acts as a potent and reversible "blood thinner".

Core Medical Information

  • Mechanism of Action: It binds directly and reversibly to both the active catalytic site and the exosite-1 of thrombin. This prevents thrombin from converting fibrinogen into fibrin, effectively blocking the final step of blood clot formation.
  • Primary Clinical Indications:
  • Pharmacokinetics: Administered strictly via intravenous (IV) bolus followed by continuous infusion. It has a very short elimination half-life of approximately 25 minutes in patients with normal renal function, primarily cleared by internal proteolysis (80%) and renal excretion (20%).
  • Main Adverse Effects: The most critical risk is bleeding. However, clinical studies (such as REPLACE-2 and HORIZONS-AMI) have shown that bivalirudin carries a lower risk of severe bleeding complications compared to traditional heparin-based regimens.


苏州法默赛科技有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

以“关爱生命、健康至上、可负担的API”为使命,我们希望与您携手合作,实现共赢,共同促进健康生活。 我司主要产品包括 司美格鲁肽、替尔泊肽、利拉鲁肽、依替巴肽、加尼瑞克、醋酸格拉替雷、特利加压素乙酸盐、奥曲肽乙酸盐、催产素乙酸盐、去氨加压素、亮丙瑞林、醋酸西曲瑞克、醋酸卡贝缩宫素、醋酸阿托西班、利那洛肽。
业务类型:
成立日期:
年营业额:
主营产品类别: